Literature DB >> 9151834

Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI.

T W Chun1, K Chadwick, J Margolick, R F Siliciano.   

Abstract

CD4+ T lymphocytes of individuals infected with human immunodeficiency virus type 1 (HIV-1) exhibit a qualitative defect in their ability to mount memory responses to previously encountered antigens although their responses to mitogens remain normal. T cells responsible for memory responses can be distinguished from naive T cells based on differential expression of isoforms of the tyrosine phosphatase CD45. It has been suggested that memory CD4+ T cells from infected individuals have a greater virus burden than naive CD4+ T cells and that this accounts for the loss of recall responses in infected individuals. However, it has been unclear whether naive and memory T cells are equally susceptible to infection and to the cytopathic effects of the virus. We therefore infected highly purified resting naive and memory CD4+ T cells from HIV-1-seronegative individuals with HIV-1(LAI). Infected cells were then stimulated with phytohemagglutinin to render them permissive for viral replication. Cell viability and growth rate were monitored for 8 to 10 days as indicators of cytopathic effects induced by HIV-1(LAI). Our results indicated that naive and memory CD4+ T cells display marked differences in susceptibility to the cytopathic effects induced by HIV-1(LAI), infection. The cytopathic effects induced by HIV-1(LAI) were much more severe in memory CD4+ T cells than in naive CD4+ T cells. Differential cytopathic effects in naive and memory T cells were not due to differences in virus entry into and replication in these cell populations. Rather, memory cells were more susceptible to cytopathic effects. Pronounced cytopathic effects in memory cells were clearly detectable at 7 day postinfection. Cell death occurred at the single-cell level and was not accompanied by syncytium formation. The growth rate of infected memory CD4+ T cells was also severely compromised compared to that of naive CD4+ T cells, whereas the growth rates of both uninfected naive and memory CD4+ T cells were approximately the same. At least a portion of the dying cells exhibited biochemical changes characteristic of apoptosis. These results suggest that the selective functional defects present in the memory CD4+ T-cell subset of HIV-1-infected individuals may in part be the result of the greater susceptibility of memory T cells to cytopathic effects induced by HIV-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151834      PMCID: PMC191662     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.

Authors:  C Terai; R S Kornbluth; C D Pauza; D D Richman; D A Carson
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

2.  Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1.

Authors:  Y Y Lu; Y Koga; K Tanaka; M Sasaki; G Kimura; K Nomoto
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

3.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

4.  The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.

Authors:  H Choe; M Farzan; Y Sun; N Sullivan; B Rollins; P D Ponath; L Wu; C R Mackay; G LaRosa; W Newman; N Gerard; C Gerard; J Sodroski
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

Review 5.  Lymphocyte recirculation and life span in vivo.

Authors:  A J Young; J B Hay; C R Mackay
Journal:  Curr Top Microbiol Immunol       Date:  1993       Impact factor: 4.291

6.  An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.

Authors:  P E Stanhope; A Y Liu; W Pavlat; P M Pitha; M L Clements; R F Siliciano
Journal:  J Immunol       Date:  1993-05-15       Impact factor: 5.422

7.  A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.

Authors:  B J Doranz; J Rucker; Y Yi; R J Smyth; M Samson; S C Peiper; M Parmentier; R G Collman; R W Doms
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

8.  The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing.

Authors:  Y Koga; K Nakamura; M Sasaki; G Kimura; K Nomoto
Journal:  Virology       Date:  1994-05-15       Impact factor: 3.616

9.  Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.

Authors:  M I Bukrinsky; T L Stanwick; M P Dempsey; M Stevenson
Journal:  Science       Date:  1991-10-18       Impact factor: 63.714

10.  Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis.

Authors:  N K Banda; J Bernier; D K Kurahara; R Kurrle; N Haigwood; R P Sekaly; T H Finkel
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

View more
  25 in total

1.  Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

Authors:  T Pierson; T L Hoffman; J Blankson; D Finzi; K Chadwick; J B Margolick; C Buck; J D Siliciano; R W Doms; R F Siliciano
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells.

Authors:  Dimitrios N Vatakis; Gregory Bristol; Thomas A Wilkinson; Samson A Chow; Jerome A Zack
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  The Activation State of CD4 T Cells Alters Cellular Peptidase Activities, HIV Antigen Processing, and MHC Class I Presentation in a Sequence-Dependent Manner.

Authors:  Julie Boucau; Julien Madouasse; Georgio Kourjian; Christopher S Carlin; Daniel Wambua; Matthew J Berberich; Sylvie Le Gall
Journal:  J Immunol       Date:  2019-04-01       Impact factor: 5.422

4.  Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.

Authors:  T Shioda; H Kato; Y Ohnishi; K Tashiro; M Ikegawa; E E Nakayama; H Hu; A Kato; Y Sakai; H Liu; T Honjo; A Nomoto; A Iwamoto; C Morimoto; Y Nagai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells.

Authors:  X J Yao; A J Mouland; R A Subbramanian; J Forget; N Rougeau; D Bergeron; E A Cohen
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1.

Authors:  S Imlach; S McBreen; T Shirafuji; C Leen; J E Bell; P Simmonds
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  A non-linear mixed effect dynamic model incorporating prior exposure and adherence to treatment to describe long-term therapy outcome in HIV-patients.

Authors:  Line Labbé; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-06-20       Impact factor: 2.745

8.  Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection.

Authors:  Theodore C Pierson; Yan Zhou; Tara L Kieffer; Christian T Ruff; Christopher Buck; Robert F Siliciano
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling.

Authors:  Guochun Jiang; Erica A Mendes; Philipp Kaiser; Sumathi Sankaran-Walters; Yuyang Tang; Mariana G Weber; Greg P Melcher; George R Thompson; Amilcar Tanuri; Luiz F Pianowski; Joseph K Wong; Satya Dandekar
Journal:  AIDS       Date:  2014-07-17       Impact factor: 4.177

10.  Vaccination with SIVmac239Deltanef activates CD4+ T cells in the absence of CD4 T-cell loss.

Authors:  R K Reeves; J Gillis; F E Wong; R P Johnson
Journal:  J Med Primatol       Date:  2009-10       Impact factor: 0.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.